The human intestine is inherently inhabited by gut microbiota. Recent studies indicate that the composition of human gut microbiota is associated with various kinds of diseases. Bifidobacteria are one of the predominant beneficial bacteria in the human gut microbiota that have been demonstrated to elicit various beneficial physiological effects in the host. The genus
Bifidobacterium is classified into Human-Residential Bifidobacteria (HRB) and non-Human-Residential Bifidobacteria (non-HRB) strains based on their residential habitats. In the present study, we focused on the characteristic features and physiological effects of HRB. We investigated folate production in bifidobacterial strains as the fundamental difference between the HRB and non-HRB strains. We found that the folate production capability of HRB species is generally higher than that of non-HRB species. Furthermore, we studied the molecular mechanisms of the physiological effects of an HRB strain,
Bifidobacterium longum subsp.
longum BB536, using multi-omics analysis comprising metabolome, metatranscriptome and metagenome analyses. We found that
B. longum BB536 alters gut luminal metabolism through interaction with the gut microbial community. These results suggest the potential of HRB to impact host health by modulating the intestinal environment via not only direct production of metabolites but also through crosstalk with the gut microbiota.
View full abstract